share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director SMITH JAMES C

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director SMITH JAMES C

輝瑞 | 4:持股變動聲明-董事 SMITH JAMES C
美股sec公告 ·  07/02 08:49
牛牛AI助理已提取核心訊息
In a recent transaction, James C. Smith, a reporting person for Pfizer Inc [PFE], executed a stock transaction on June 28, 2024. The details of the transaction, including the number of shares traded, the nature of the shares, the transaction price, and the total value of the shares, were not disclosed in the announcement. The relationship of James C. Smith to Pfizer was not specified, and the current number of shares held by Smith after the transaction remains undisclosed.
In a recent transaction, James C. Smith, a reporting person for Pfizer Inc [PFE], executed a stock transaction on June 28, 2024. The details of the transaction, including the number of shares traded, the nature of the shares, the transaction price, and the total value of the shares, were not disclosed in the announcement. The relationship of James C. Smith to Pfizer was not specified, and the current number of shares held by Smith after the transaction remains undisclosed.
據報道,輝瑞公司(PFE)的報告人詹姆斯·C·史密斯於2024年6月28日進行了股票交易。交易細節,包括交易股票的數量、性質、交易價格以及股票的總價值,在公告中沒有被披露。史密斯與輝瑞公司的關係沒有被具體說明,交易後史密斯持有的股票數量也沒有被公開。
據報道,輝瑞公司(PFE)的報告人詹姆斯·C·史密斯於2024年6月28日進行了股票交易。交易細節,包括交易股票的數量、性質、交易價格以及股票的總價值,在公告中沒有被披露。史密斯與輝瑞公司的關係沒有被具體說明,交易後史密斯持有的股票數量也沒有被公開。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。